NCT07116512View on ClinicalTrials.gov

A Study to Compare How Much of the Study Treatment Finerenone Gets Into the Blood When the Same Amount is Taken in One and in Two Tablets of Different Strengths in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 2, 2023

Primary Completion Date

July 28, 2023

Study Completion Date

July 28, 2023

Conditions
Heart Failure With Left Ventricular Ejection Fraction Greater Than or Equal to 40 Per CentHealthy Volunteers
Interventions
DRUG

Finerenone (BAY94-8862): intervention A

Study intervention A: one tablet of dose strength 1 one tablet of dose strength 1 = two tablets of dose strength 2

DRUG

Finerenone (BAY94-8862): intervention B

Study intervention B: two tablets of dose strength 2 two tablets of dose strength 2 = one tablet of dose strength 1

Trial Locations (1)

42113

CRS Clinical Research Services Wuppertal GmbH, Wuppertal

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT07116512 - A Study to Compare How Much of the Study Treatment Finerenone Gets Into the Blood When the Same Amount is Taken in One and in Two Tablets of Different Strengths in Healthy Male Participants | Biotech Hunter | Biotech Hunter